POSTER SESSION IV Tuesday, March 25, 2003   —  1:00 - 4:30 PM Exhibit Hall A - C GYNECOLOGIC PATHOLOGY 120 Erythropoietin Signaling in Cervical Carcinoma: A Pathway of Hypoxia-Mediated Treatment Resistance (810) G Acs, PJ Zhang, A Mohyeldin, S Liu, H Lu, J McBroom, A Verma University of Pennsylvania Medical Center, Philadelphia, PA; Uniformed Services University of the Health Sciences, Bethesda, MD; Walter Reed Army Medical Center, Washington, DC 121 Expression of Erythropoietin and Its Receptor in Squamous Dysplasia of the Uterine Cervix: Correlation with Expression of p16, HIF-1" and bcl-2, and Potential Role in Cervical Carcinogenesis (811) G Acs, PJ Zhang, CM McGrath, A Verma University of Pennsylvania Medical Center, Philadelphia, PA; Uniformed Services University of the Health Sciences, Bethesda, MD 122 Eukaryotic Translation Initiation Factor 4E Could Be a Useful Marker for Cervical Neoplasia (968) EA Turbat-Herrera, A de Benedetti, GA Herrera, A Tucker, H Dominguez-Malagon, J Chanona Vilchis, J Matthews-Greer LSU Health Sciences Center, Shreveport, LA; Overton Brooks VA Medical Center, Shreveport, LA; Instituto de Cancerologia, D.F., Mexico 123 Focal Adhesion Kinase (FAK) as a Marker of Malignant Phenotype in Cervical Carcinoma (925) MH Oktay, KH Oktay, D Hamele-Bena, LG Koss Montefiore Medical Center, Bronx, NY; Weill Medical College of Cornell University, New York, NY; Columbia-Presbyterian Hospital, New York, NY 124 Telomerase and Ki67 Immunohistochemistry as Diagnostic Markers for Cervical Cancer (873) A Heras, G Ghirardi, F Maldonado, S Cordova, J Arias-Stella, Jr BIO SB, Inc, Santa Barbara, CA; Hospital Cordoba, Cordoba, Argentina; Instituto de Patologia y Biologia Molecular Arias Stella, Lima, Peru 125 p53 Degradation in HPV Induced Cervical Carcinoma Occurs before the Malignant Transformation of Dysplastic Cells (822) I Anton, JA Ortiz-Rey, P San Miguel, C Alvarez, A De La Fuente Centro Medico Povisa, Vigo, Pontevedra, Spain 126 Expression of Vascular Endothelial Growth Factor in Progression of Cervical Neoplasia and Its Relation to Angiogenesis and p53 Protein Expression (892) JS Lee, YB Kim, MC Lee, CS Park, KW Min Seonam University, College of Medicine, Namwon, Republic of Korea; Chonnam University Medical School, Gwangju, Republic of Korea; Deaconess Hospital, Oklahoma, OK 127 Histologic and Immunohistochemical Features Distinguishing 2 Groups in Atypical Squamous Lesions of Uterine Cervix (823) C Aoyama, CH Holschneider, P Liu Olive View-UCLA Medical Center, Sylmar, CA 128 P16ink4 Expression Patterns in LSIL Support the Existence of Multiple Biologic Subsets (814) D Aldovini, A Cviko, L Yuan, MR Nucci, CP Crum Chiara Hospital, Trento, Italy; Brigham and Women's Hospital, Boston, MA 129 Expression of Prostaglandin H-Synthase (COX2) in Lesions of the Uterine Cervix (864) MK Garcia, PA Adegboyega University of Texas Medical Branch, Galveston, TX 130 Detection of Human Papillomavirus by Hybrid Capture II in the Follow-Up of Cervical Lesions Treated with Excisional Methods (839) A Casado, J Ordi, B Ferrer, LM Puig-Tintore, A Torne, P Jou, R Esteve, X Iglesias, A Cardesa IDIBAPS-Hospital Clinic, University of Barcelona, School of Medicine, Barcelona, Spain 131 Molecular Analysis of HPV by Hybrid Capture and DNA Array in ASCUS (890) P Kirshman, M Moore, D Baunoch, R Gasparini, KJ Bloom US Labs, Irvine, CA 132 Detection of Human Papillomavirus by Hybrid Capture II in the Evaluation of Lesions of the Uterine Cervix (948) C Romagosa, J Ordi, LM Puig-Tintore, A Torne, P Jou, R Esteve, M Sole, X Iglesias, A Cardesa IDIBAPS-Hospital Clinic, University of Barcelona, School of Medicine, Barcelona, Spain 133 Evaluation of Margin and Extent of Dysplasia in LEEP Biopsies Performed for High Grade Squamous Intraepithelial Lesion (HSIL) (969) LN Tyler, T Parmley, S Korourian University of Arkansas for Medical Sciences, Little Rock, AR 134 Negative Cervical Leep after Biopsy-Confirmed High Grade Dysplasia: Incidence, Clinical Significance and Histologic Features (906) CA Livasy, L Van Le University of North Carolina, Chapel Hill, NC 135 Histological Predictors of Residual Lesions in High Grade Squamous Intraepithelial Lesions (HSIL) of the Uterine Cervix after LEEP Conization (888) HJ Kim, JY Ro, K-R Kim University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea 136 Arias-Stella Reaction of the Endocervix: A Study of 14 Cases with Emphasis on Its Varied Morphology (924) MR Nucci, RH Young Brigham and Women's Hospital, Boston, MA; Massachusetts General Hospital, Boston, MA 137 Distinction of Endocervical and Endometrial Adenocarcinomas: p16 Expression Correlated with Human Papillomavirus (HPV) DNA Detection by In Situ Hybridization (ISH) (821) MA Ansari-Lari, A Staebler, BM Ronnett The Johns Hopkins Medical Institutions, Baltimore, MD 138 Immunohistochemical Profiles of Endometrial and Endocervical Adenocarcinomas (989) Z Lin, X Zhang, ES Lee, I Kim Korea University Medical College, Seoul, Korea 139 Can CD10 and Mucin Stains Distinguish Endocervix from Lower Uterine Segment? (974) MM Weir, CM McLachlin London Health Sciences Centre & University of Western Ontario, London, ON, Canada 140 Early Invasive Adenocarcinoma of the Cervix: Results of Surgical Staging and Outcome Analysis (959) D Shaw, D Langlois, D Daya, K Ceballos McMaster University, Hamilton, ON 141 Obstacles to Early Detection of Endocervical Adenocarcinoma (856) RI Demopoulos, M Backus NYU Medical Center, New York, NY 142 Evaluation of Her-2/neu Status by Immunohistochemistry (IHC) and Fluorescent In-Situ Hibridization (FISH) in Cervical Adenocarcinoma (945) G Rasty, A Covens, M Khalifa University of Toronto, Toronto, ON, Canada 143 Angiogenesis and Cell Proliferation Markers in Cervical Adenocarcinoma (934) D Perez-Montiel, M Chavez-McGregor, D Cantu de Leon Instituto Nacional de Cancerologia, Mexico City, Mexico 144 Paget's Disease of the Cervix (838) S Carinelli, G Scarfone, V Bianco Instituti Clinici di Perfezionamento, Milan, Italy 145 Cervical Adenoid Basal Tumors Associated with Invasive Carcinoma: Clinicopathologic Features, Human Papillomavirus (HPV) DNA Detection, and p16 Over-Expression (933) AV Parwani, AE Smith-Sehdev, RJ Kurman, BM Ronnett The Johns Hopkins Hospital, Baltimore, MD 146 Immunohistochemical Characterization of Endocervical Papillary Serous Carcinoma (PSC) (886) M Khalifa, A Covens, G Rasty University of Toronto, Toronto, ON, Canada 147 Cervical Small Cell Carcinoma and Large Cell Neuroendocrine Carcinoma Express c-Kit, c-Abl, and PDGFR (855) MT Deavers, A Malpica, PT Ramirez, A Viswanathan, A Jhingran, EG Silva, PJ Eifel M. D. Anderson Cancer Center, Houson, TX; M. D. Anderson Cancer Center, Houston, TX